Limited Offer
Translational Research in Cardio-Oncology, An Issue of Heart Failure Clinics
- 1st Edition, Volume 18-3 - June 21, 2022
- Editors: Ragavendra R. Baliga, George A. Mensah
- Language: English
- Hardback ISBN:9 7 8 - 0 - 3 2 3 - 9 8 7 4 7 - 9
- eBook ISBN:9 7 8 - 0 - 3 2 3 - 9 8 7 4 8 - 6
In this issue of Heart Failure Clinics, guest editors Drs. Ragavendra R Baliga and George A. Mensah bring their considerable expertise to the topic of Translational Research in Ca… Read more
Purchase options
Institutional subscription on ScienceDirect
Request a sales quote-
Contains 12 relevant, practice-oriented topics including cardio-protection of high-risk individuals; myocardial metabolism; amyloidosis; arrhythmic complications associated with cancer therapies; and more.
-
Provides in-depth clinical reviews on translational research in cardio-oncology, offering actionable insights for clinical practice.
-
Presents the latest information on this timely, focused topic under the leadership of experienced editors in the field. Authors synthesize and distill the latest research and practice guidelines to create clinically significant, topic-based reviews.
- Cover image
- Title page
- Table of Contents
- Copyright
- Contributors
- Forthcoming Issues
- Preface
- Modeling Susceptibility to Cardiotoxicity in Cancer Therapy Using Human iPSC-Derived Cardiac Cells and Systems Biology
- Key points
- Introduction
- Genomics
- Transcriptomics
- Epitranscriptomics
- Epigenetics
- Future of functional genomics in cardio-oncology modeling using human-induced pluripotent stem cells
- Summary
- Clinics care points
- Therapy-Related Clonal Hematopoiesis: A New Link Between Cancer and Cardiovascular Disease
- Key points
- Introduction
- What is clonal hematopoiesis?
- Clonal hematopoiesis is associated with cardiovascular disease
- Clonal hematopoiesis is associated with heart failure
- Therapy-associated clonal hematopoiesis is prevalent in patients with cancer
- Possible links between therapy-associated clonal hematopoiesis and cardiovascular disease
- Summary and future directions
- Clinics care points
- Funding
- Disclosure
- Myocardial Dysfunction in Patients with Cancer
- Key points
- Introduction
- Prevalence of myocardial dysfunction in patients with cancer
- Myocardial dysfunction associated with cancer
- Monitoring for and management of CTRCD
- Summary
- Clinics care points
- Disclosure statement
- Arrhythmic Complications Associated with Cancer Therapies
- Key points
- Introduction
- Atrial fibrillation and other atrial arrhythmias
- Ventricular arrhythmias
- Bradyarrhythmias and Autonomic Dysfunction
- Autonomic dysfunction in cancer
- Summary
- Clinics care points
- Cardioprotection of High-Risk Individuals
- Key points
- Introduction
- Risk stratification
- Cardioprotective strategies of anthracyclines
- Cardioprotective strategies with anti–human-epidermal growth factor receptor-2 therapy
- Shorter duration of human-epidermal growth factor receptor-2 targeted therapies
- Cardioprotective strategies with radiation
- Cardioprotective strategies with hematopoietic cell transplantation
- Cardioprotective strategies: vascular endothelial growth factor inhibitors
- Cardioprotective strategies with fluoropyrimidines
- Cardioprotective strategies with BCR-Abl tyrosine kinase inhibitors
- Cardioprotective strategies with immune checkpoint inhibitors
- Clinics care points
- Radiation-Induced Cardiac Dysfunction: Optimizing Radiation Delivery and Postradiation Care
- Key points
- Introduction
- Elements of radiation therapy delivery impacting radiation-induced cardiac dysfunction risk
- Other factors impacting radiation-induced cardiac dysfunction risk
- Automated electronic medical record tracking and physician notification as a potential strategy to better detect and treat radiation-induced cardiac dysfunction
- Discussion and summary
- Clinics care points
- Understanding Myocardial Metabolism in the Context of Cardio-Oncology
- Key points
- Introduction
- Anthracyclines and myocardial metabolism
- Epigenetic regulation in cancer and myocardial metabolism
- Current newer agents in cancer therapy affect metabolism, specifically myocardial metabolism
- Interaction between tumor and myocardial metabolism
- Future directions
- Funding support
- Intracellular Signaling Pathways Mediating Tyrosine Kinase Inhibitor Cardiotoxicity
- Key points
- Introduction
- Tyrosine kinase inhibitors and mechanism of action
- Receptor signaling pathways and cardiomyopathy
- Tyrosine kinase inhibitor-induced cardiovascular dysfunction
- Tyrosine kinase inhibitors and heart failure
- Current and proposed treatments for tyrosine kinase inhibitor -induced toxicity
- Summary and future directions
- Clinics care points
- Funding
- T-cell Immunotherapy and Cardiovascular Disease: Chimeric Antigen Receptor T-cell and Bispecific T-cell Engager Therapies
- Key points
- Introduction
- Mechanisms of chimeric antigen receptor T-cell and bispecific T-cell engager therapies
- Cytokine release syndrome
- Mechanisms of cardiotoxicity
- Clinical evidence of cardiotoxicity
- Risk factors for cardiotoxicity
- Clinical management
- Novel cardiovascular targeted chimeric antigen receptor T-cell therapies
- Summary
- Clinics care points
- Disclosures
- Cardiovascular Imaging in Cardio-Oncology: The Role of Echocardiography and Cardiac MRI in Modern Cardio-Oncology
- Key points
- Introduction
- Clinics care points
- Disclosure
- Funding
- Cardiac Amyloidosis
- Key points
- Introduction
- Summary
- Clinics care points
- Funding
- Clinical Practice Guidelines in Cardio-Oncology
- Key points
- Introduction
- Discussion
- Cardiotoxicity surveillance
- Summary
- Clinics care points
- Training and Career Development in Cardio-Oncology Translational and Implementation Science
- Key points
- Introduction
- Infrastructure for training
- Opportunities for training
- Career development
- Summary
- Spectrum of National Institutes of Health-Funded Research in Cardio-Oncology: A Basic, Clinical, and Observational Science Perspective
- Key points
- Introduction
- National Institutes of Health Workshops and funding opportunity announcements
- Spectrum of National Institutes of Health -supported research projects
- Research training and fellowships
- Summary and future directions
- Disclosure
- Disclaimer
- No. of pages: 240
- Language: English
- Edition: 1
- Volume: 18-3
- Published: June 21, 2022
- Imprint: Elsevier
- Hardback ISBN: 9780323987479
- eBook ISBN: 9780323987486
RB
Ragavendra R. Baliga
GM